Cargando…
The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer
BACKGROUND: Systemic inflammation, the most representative tumour–host interaction, plays a crucial role in disease progression and prognosis in patients with non‐small cell lung cancer (NSCLC). Few studies have compared the performance of existing haematological systemic inflammation biomarkers in...
Autores principales: | Xie, Hailun, Ruan, Guotian, Wei, Lishuang, Deng, Li, Zhang, Qi, Ge, Yizhong, Song, Mengmeng, Zhang, Xi, Lin, Shiqi, Liu, Xiaoyue, Yang, Ming, Song, Chunhua, Zhang, Xiaowei, Shi, Hanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067487/ https://www.ncbi.nlm.nih.gov/pubmed/36852672 http://dx.doi.org/10.1002/jcsm.13199 |
Ejemplares similares
-
A novel inflammation-nutrition biomarker score for predicting prognosis of patients with cancer: results from a multicenter study
por: Xie, Hailun, et al.
Publicado: (2022) -
Combination of Nutritional Risk Index and Handgrip Strength on the Survival of Patients with Cancer Cachexia: A Multi- Center Cohort Study
por: Xie, Hailun, et al.
Publicado: (2022) -
Comprehensive comparative analysis of prognostic value of serum systemic inflammation biomarkers for colorectal cancer: Results from a large multicenter collaboration
por: Xie, Hailun, et al.
Publicado: (2023) -
Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer
por: Xie, Hailun, et al.
Publicado: (2022) -
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
por: Song, Mengmeng, et al.
Publicado: (2022)